• Abstract and Figures
• Public Full-text

Federal Register / Vol. 85, No. 249 / Tuesday, December 29, 2020 / Notices 85831 cautioned that we do not redact or edit The Commission estimates that, on of China’s acts, policies, and practices personal identifying information from average, approximately one respondent related to technology transfer, comment submissions. You should submits a Form 2–E filing each year. intellectual property, and innovation by submit only information that you wish The Commission further estimates that excluding from additional duties certain to make available publicly. All this information collection imposes an medical-care products needed to submissions should refer to File annual burden of four hours and address the COVID–19 outbreak. On Number SR–NYSEARCA–2020–112 and imposes an annual external cost burden March 25, 2020, the U.S. Trade should be submitted on or before of zero. Representative sought public comment January 19, 2021. The collection of information under on additional modifications in this For the Commission, by the Division of Form 2–E is mandatory. The investigation in order to address Trading and Markets, pursuant to delegated information provided by the form will COVID–19. This notice announces the authority.28 not be kept confidential. An agency may U.S. Trade Representative’s J. Matthew DeLesDernier, not conduct or sponsor, and a person is determination to extend certain product Assistant Secretary. not required to respond to, a collection exclusions and to make further [FR Doc. 2020–28659 Filed 12–28–20; 8:45 am] of information unless it displays a modifications to remove Section 301 BILLING CODE 8011–01–P currently valid OMB control number. duties from additional medical-care Written comments are invited on: (a) products to address COVID–19. Whether the proposed collection of DATES: The product exclusion SECURITIES AND EXCHANGE information is necessary for the proper extensions announced in this notice COMMISSION performance of the functions of the will extend the exclusions through agency, including whether the March 31, 2021. The modifications to Proposed Collection; Comment information will have practical utility; exclude additional products will apply Request (b) the accuracy of the agency’s estimate as of January 1, 2021 until March 31, Upon Written Request, Copies Available of the burden of the collection of 2021. U.S. Customs and Border From: Securities and Exchange information; (c) ways to enhance the Protection will issue instructions on Commission, Office of FOIA Services, quality, utility, and clarity of the entry guidance and implementation. 100 F Street NE, Washington, DC information collected; and (d) ways to FOR FURTHER INFORMATION CONTACT: For 20549–2736 minimize the burden of the collection of general questions about this notice, information on respondents, including contact Associate General Counsel Extension: through the use of automated collection Form 2–E, Report pursuant to rule 609 of Philip Butler, Assistant General Regulation E, SEC File No. 270–222, techniques or other forms of information Counsels Benjamin Allen or Susie Park OMB Control No. 3235–0233 technology. Consideration will be given Hodge, or Director of Industrial Goods to comments and suggestions submitted Justin Hoffmann at (202) 395–5725. For Notice is hereby given that, pursuant in writing within 60 days of this to the Paperwork Reduction Act of 1995 specific questions on customs publication. classification or implementation of the (44 U.S.C. 3501 et seq.), the Securities Please direct your written comments and Exchange Commission (the product exclusions identified in the to David Bottom, Director/Chief Annexes to this notice, contact ‘‘Commission’’) is soliciting comments Information Officer, Securities and on the collection of information [email protected]. Exchange Commission, c/o Cynthia summarized below. The Commission SUPPLEMENTARY INFORMATION: Roscoe, 100 F Street NE, Washington, plans to submit this existing collection DC 20549; or send an email to: PRA_ A. Background of information to the Office of [email protected]. Management and Budget (‘‘OMB’’) for At the direction of the President, the extension and approval. Dated: December 22, 2020. U.S. Trade Representative imposed Rule 609 (17 CFR 230.609) under the Eduardo A. Aleman, additional duties on products of China Securities Act of 1933 (15 U.S.C. 77a et Deputy Secretary. in order to obtain the elimination of the seq.) requires small business investment [FR Doc. 2020–28769 Filed 12–28–20; 8:45 am] unfair and damaging acts, policies, and companies and business development BILLING CODE 8011–01–P practices identified in this investigation. companies that have engaged in These additional duties were imposed offerings of securities that are exempt in four tranches. See 83 FR 28719 (June from registration pursuant to Regulation 20, 2018), 83 FR 40823 (August 16, OFFICE OF THE UNITED STATES E under the Securities Act of 1933 (17 2018), 83 FR 47974 (September 21, TRADE REPRESENTATIVE CFR 230.601 to 610a) to report semi- 2018), as modified by 83 FR 49153 annually on Form 2–E (17 CFR 239.201) Notice of Product Exclusion (September 28, 2018), and 84 FR 43304 the progress of the offering. The form Extensions and Additional (August 20, 2019), as modified by 84 FR solicits information such as the dates an Modifications: China’s Acts, Policies, 69447 and 85 FR 3741. offering commenced and was completed and Practices Related to Technology For each tranche, the U.S. Trade (if completed), the number of shares Transfer, Intellectual Property, and Representative established a process by sold and still being offered, amounts Innovation which U.S. stakeholders could request received in the offering, and expenses the exclusion of particular products and underwriting discounts incurred in AGENCY: Office of the United States subject to the action. Additionally, the the offering. The information provided Trade Representative (USTR). U.S. Trade Representative later on Form 2–E assists the staff in ACTION: Notice of product exclusion established a process by which U.S. monitoring the progress of the offering extensions and additional stakeholders could request the and in determining whether the offering modifications. extension of particular exclusions. has stayed within the limits set for an Throughout the exclusion process, offering exempt under Regulation E. SUMMARY: In prior notices, the U.S. USTR assessed medical necessity in Trade Representative modified the granting exclusions, consistent with its 28 17 CFR 200.30–3(a)(12). action in the Section 301 investigation published criteria. In addition, the U.S. VerDate Sep<11>2014 00:55 Dec 29, 2020 Jkt 253001 PO 00000 Frm 00253 Fmt 4703 Sfmt 4703 E:\FR\FM\29DEN1.SGM 29DEN1 KHAMMOND on DSKJM1Z7X2PROD with NOTICES 85832 Federal Register / Vol. 85, No. 249 / Tuesday, December 29, 2020 / Notices Trade Representative, in consultation investigation, regardless of whether the of the evolving nature of the battle with the Department of Health and product was subject to a pending or against COVID–19, the U.S. Trade Human Services (HHS), prioritized the denied exclusion request. Representative has determined to review and exclusion of requests B. Determination To Extend Certain extend the exclusions in the annexes addressing medical-care products Exclusions and Make Additional until March 31, 2021, and the related to the U.S. response to COVID– Modifications modifications will be effective from 19. See 85 FR 13970 (March 10, 2020), January 1, 2021, to March 31, 2021. The 85 FR 15015 (March 16, 2020), and 85 In light of the rising spread and U.S. Trade Representative may consider FR 15244 (March 17, 2020). These ongoing efforts to combat COVID–19, further extensions and/or additional exclusions covered personal protective the U.S. Trade Representative has modifications as appropriate. The U.S. determined that maintaining or re- equipment products and other medical- Trade Representative’s determination imposing additional duties on certain care related products. also takes into account advice from products subject to the action no longer advisory committees and any public On March 25, 2020, in order to reflect is appropriate and that the application developments in the efforts to respond of additional duties to these products comments. to COVID–19, the U.S. Trade could impact U.S. preparedness to The exclusions and modifications are Representative requested public address COVID–19. available for any product that meets the comments on possible further Pursuant to sections 301(b), 301(c), description in the Annexes. Further, the modifications to remove Section 301 and 307(a) of the Trade Act of 1974, as scope of each exclusion and duties from additional medical-care amended, and in accordance with the modification is governed by the scope of products to address the COVID–19 advice of the interagency Section 301 the ten-digit Harmonized Tariff outbreak. 85 FR 16987 (March 25, 2020). Committee, the U.S. Trade Schedule of the United States (HTSUS) This docket was open from March 25– Representative has determined to subheadings and product descriptions June 25, 2020, and each commenter was extend certain product exclusions on in the annexes to this notice. required to identify the particular medical-care products and to remove product of concern and explain how it the duties from additional medical-care Joseph Barloon, relates to the response to COVID–19. products. The medical-care products General Counsel, Office of the United States USTR accepted comments regarding any covered by this determination are set Trade Representative. product covered by the action in the out in the annexes to this notice. In light BILLING CODE 3290–F0–P VerDate Sep<11>2014 00:55 Dec 29, 2020 Jkt 253001 PO 00000 Frm 00254 Fmt 4703 Sfmt 4703 E:\FR\FM\29DEN1.SGM 29DEN1 KHAMMOND on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 85, No. 249 / Tuesday, December 29, 2020 / Notices 85833 VerDate Sep<11>2014 00:55 Dec 29, 2020 Jkt 253001 PO 00000 Frm 00255 Fmt 4703 Sfmt 4725 E:\FR\FM\29DEN1.SGM 29DEN1 KHAMMOND on DSKJM1Z7X2PROD with NOTICES EN29DE20.415</GPH> 85834 Federal Register / Vol.

Load more

  16

Copy Link